Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan D Michelson

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
Thrombosis Research|December 1, 2009
Agonist and antagonist effects of diadenosine tetraphosphate, a platelet dense granule constituent, on platelet P2Y1, P2Y12 and P2X1 receptorsHung Chang, Ivan B Yanachkov, Alan D Michelson, et al.
Blood|November 9, 2002
Two novel mutations in the alpha IIb calcium-binding domains identify hydrophobic regions essential for alpha IIbbeta 3 biogenesisW Beau Mitchell, Ji Hong Li, Fiza Singh, et al.
Platelets|August 13, 2010
Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney functionMaria Lajer, Inge Tarnow, Alan D Michelson, et al.
Blood|July 12, 2003
Spirochete-platelet attachment and thrombocytopenia in murine relapsing fever borreliosisKishore R Alugupalli, Alan D Michelson, Isabelle Joris, et al.
Scientific Reports|December 1, 2018
Publisher Correction: GLS-409, an Antagonist of Both P2Y<sub>1</sub> and P2Y<sub>12</sub>, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet ActivationElena Smolensky Koganov, Alan D Michelson, Ivan B Yanachkov, et al.
Scientific Reports|September 30, 2018
GLS-409, an Antagonist of Both P2Y<sub>1</sub> and P2Y<sub>12</sub>, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet ActivationElena Smolensky Koganov, Alan D Michelson, Ivan B Yanachkov, et al.
Circulation|June 21, 2006
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistanceAndrew L Frelinger, Mark I Furman, Matthew D Linden, et al.
Pediatrics|January 5, 2011
Hormonal contraception and thrombotic risk: a multidisciplinary approachCameron C Trenor, Richard J Chung, Alan D Michelson, et al.
Plos One|April 23, 2021
Activation of platelet-rich plasma by pulse electric fields: Voltage, pulse width and calcium concentration can be used to control and tune the release of growth factors, serotonin and hemoglobinBogdan Neculaes, Andrew L Frelinger, Anja J Gerrits, et al.
Atherosclerosis|November 22, 2021
Sex-specific platelet activation through protease-activated receptor-1 in patients undergoing cardiac catheterizationThomas Gremmel, Alan D Michelson, Patricia P Wadowski, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
Thrombosis Research|December 1, 2009
Agonist and antagonist effects of diadenosine tetraphosphate, a platelet dense granule constituent, on platelet P2Y1, P2Y12 and P2X1 receptorsHung Chang, Ivan B Yanachkov, Alan D Michelson, et al.
Blood|November 9, 2002
Two novel mutations in the alpha IIb calcium-binding domains identify hydrophobic regions essential for alpha IIbbeta 3 biogenesisW Beau Mitchell, Ji Hong Li, Fiza Singh, et al.
Platelets|August 13, 2010
Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney functionMaria Lajer, Inge Tarnow, Alan D Michelson, et al.
Blood|July 12, 2003
Spirochete-platelet attachment and thrombocytopenia in murine relapsing fever borreliosisKishore R Alugupalli, Alan D Michelson, Isabelle Joris, et al.
Scientific Reports|December 1, 2018
Publisher Correction: GLS-409, an Antagonist of Both P2Y<sub>1</sub> and P2Y<sub>12</sub>, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet ActivationElena Smolensky Koganov, Alan D Michelson, Ivan B Yanachkov, et al.
Scientific Reports|September 30, 2018
GLS-409, an Antagonist of Both P2Y<sub>1</sub> and P2Y<sub>12</sub>, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet ActivationElena Smolensky Koganov, Alan D Michelson, Ivan B Yanachkov, et al.
Circulation|June 21, 2006
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistanceAndrew L Frelinger, Mark I Furman, Matthew D Linden, et al.
Pediatrics|January 5, 2011
Hormonal contraception and thrombotic risk: a multidisciplinary approachCameron C Trenor, Richard J Chung, Alan D Michelson, et al.
Plos One|April 23, 2021
Activation of platelet-rich plasma by pulse electric fields: Voltage, pulse width and calcium concentration can be used to control and tune the release of growth factors, serotonin and hemoglobinBogdan Neculaes, Andrew L Frelinger, Anja J Gerrits, et al.
Atherosclerosis|November 22, 2021
Sex-specific platelet activation through protease-activated receptor-1 in patients undergoing cardiac catheterizationThomas Gremmel, Alan D Michelson, Patricia P Wadowski, et al.
Pageof 13